RETRACTED: Exosomes From Cancer-Associated Mesenchymal Stem Cells Transmit TMBIM6 to Promote the Malignant Behavior of Hepatocellular Carcinoma via Activating PI3K/AKT Pathway

ObjectiveCancer-associated mesenchymal stem cells (MSCs) regulate the progression of cancers through exosome-delivered components, while few studies are conducted on hepatocellular carcinoma (HCC). This study aimed to evaluate the effect of exosomes from HCC-associated MSCs (HCC-MSCs) on HCC cellula...

Full description

Bibliographic Details
Main Authors: Chuzhi Shang, Mi Ke, Lin Liu, Cong Wang, Yufang Liu, Xin Zheng
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-06-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.868726/full
_version_ 1827314283858362368
author Chuzhi Shang
Mi Ke
Lin Liu
Cong Wang
Yufang Liu
Xin Zheng
author_facet Chuzhi Shang
Mi Ke
Lin Liu
Cong Wang
Yufang Liu
Xin Zheng
author_sort Chuzhi Shang
collection DOAJ
description ObjectiveCancer-associated mesenchymal stem cells (MSCs) regulate the progression of cancers through exosome-delivered components, while few studies are conducted on hepatocellular carcinoma (HCC). This study aimed to evaluate the effect of exosomes from HCC-associated MSCs (HCC-MSCs) on HCC cellular functions and the potential regulatory mechanism.MethodsHCC cells (Huh7 and PLC) were cultured normally or co-cultured with HCC-MSCs, HCC-MSCs plus GW4869, or HCC-MSC-derived exosomes; then mRNA sequencing and RT-qPCR validation were conducted. Subsequently, candidate genes were sorted out and modified in HCC cells. Next, TMBIM6-modified HCC-MSCs were used to treat HCC cells.ResultsBoth HCC-MSCs and their derived exosomes promoted proliferation, invasion, sphere formation ability but suppressed apoptosis in HCC cells (all p < 0.05); however, the effect of HCC-MSCs on these cellular functions was repressed by exosome inhibitor (GW4869). Subsequently, TMBIM6, EEF2, and PRDX1 were sorted out by mRNA sequencing and RT-qPCR validation as candidate genes implicated in the regulation of HCC cellular functions by HCC-MSC-derived exosomes. Among them, TMBIM6 had a potent effect (all p < 0.05), while EEF2 and PRDX1 had less effect on regulating HCC cell viability and invasion. Next, direct silencing TMBIM6 repressed viability, sphere formation, invasion, epithelial–mesenchymal transition (EMT), and PI3K/AKT pathway but promoted apoptosis in HCC cells; however, overexpressing TMBIM6 showed the opposite effect. Furthermore, incubating with exosomes from TMBIM6-modified HCC-MSCs presented a similar effect as direct TMBIM6 modification in HCC cells.ConclusionHCC-MSC-derived exosomes transmit TMBIM6 to promote malignant behavior via PI3K/AKT pathway in HCC.
first_indexed 2024-03-11T17:37:53Z
format Article
id doaj.art-774d9f699e22411cae14212b6cfa3ee7
institution Directory Open Access Journal
issn 2234-943X
language English
last_indexed 2024-04-24T22:32:45Z
publishDate 2022-06-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj.art-774d9f699e22411cae14212b6cfa3ee72024-03-19T14:55:08ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2022-06-011210.3389/fonc.2022.868726868726RETRACTED: Exosomes From Cancer-Associated Mesenchymal Stem Cells Transmit TMBIM6 to Promote the Malignant Behavior of Hepatocellular Carcinoma via Activating PI3K/AKT PathwayChuzhi Shang0Mi Ke1Lin Liu2Cong Wang3Yufang Liu4Xin Zheng5Department of Hepatobiliary Surgery, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, ChinaDepartment of Hepatobiliary Surgery, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, ChinaDepartment of Hepatobiliary Surgery, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, ChinaDepartment of Hepatobiliary Surgery, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, ChinaDepartment of General Surgery, Shangzhou Regional Hospital, Shangluo, ChinaDepartment of Hepatobiliary Surgery, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, ChinaObjectiveCancer-associated mesenchymal stem cells (MSCs) regulate the progression of cancers through exosome-delivered components, while few studies are conducted on hepatocellular carcinoma (HCC). This study aimed to evaluate the effect of exosomes from HCC-associated MSCs (HCC-MSCs) on HCC cellular functions and the potential regulatory mechanism.MethodsHCC cells (Huh7 and PLC) were cultured normally or co-cultured with HCC-MSCs, HCC-MSCs plus GW4869, or HCC-MSC-derived exosomes; then mRNA sequencing and RT-qPCR validation were conducted. Subsequently, candidate genes were sorted out and modified in HCC cells. Next, TMBIM6-modified HCC-MSCs were used to treat HCC cells.ResultsBoth HCC-MSCs and their derived exosomes promoted proliferation, invasion, sphere formation ability but suppressed apoptosis in HCC cells (all p < 0.05); however, the effect of HCC-MSCs on these cellular functions was repressed by exosome inhibitor (GW4869). Subsequently, TMBIM6, EEF2, and PRDX1 were sorted out by mRNA sequencing and RT-qPCR validation as candidate genes implicated in the regulation of HCC cellular functions by HCC-MSC-derived exosomes. Among them, TMBIM6 had a potent effect (all p < 0.05), while EEF2 and PRDX1 had less effect on regulating HCC cell viability and invasion. Next, direct silencing TMBIM6 repressed viability, sphere formation, invasion, epithelial–mesenchymal transition (EMT), and PI3K/AKT pathway but promoted apoptosis in HCC cells; however, overexpressing TMBIM6 showed the opposite effect. Furthermore, incubating with exosomes from TMBIM6-modified HCC-MSCs presented a similar effect as direct TMBIM6 modification in HCC cells.ConclusionHCC-MSC-derived exosomes transmit TMBIM6 to promote malignant behavior via PI3K/AKT pathway in HCC.https://www.frontiersin.org/articles/10.3389/fonc.2022.868726/fullhepatocellular carcinomacancer-associated mesenchymal stem cellsexosomesTMBIM6cancer progression
spellingShingle Chuzhi Shang
Mi Ke
Lin Liu
Cong Wang
Yufang Liu
Xin Zheng
RETRACTED: Exosomes From Cancer-Associated Mesenchymal Stem Cells Transmit TMBIM6 to Promote the Malignant Behavior of Hepatocellular Carcinoma via Activating PI3K/AKT Pathway
Frontiers in Oncology
hepatocellular carcinoma
cancer-associated mesenchymal stem cells
exosomes
TMBIM6
cancer progression
title RETRACTED: Exosomes From Cancer-Associated Mesenchymal Stem Cells Transmit TMBIM6 to Promote the Malignant Behavior of Hepatocellular Carcinoma via Activating PI3K/AKT Pathway
title_full RETRACTED: Exosomes From Cancer-Associated Mesenchymal Stem Cells Transmit TMBIM6 to Promote the Malignant Behavior of Hepatocellular Carcinoma via Activating PI3K/AKT Pathway
title_fullStr RETRACTED: Exosomes From Cancer-Associated Mesenchymal Stem Cells Transmit TMBIM6 to Promote the Malignant Behavior of Hepatocellular Carcinoma via Activating PI3K/AKT Pathway
title_full_unstemmed RETRACTED: Exosomes From Cancer-Associated Mesenchymal Stem Cells Transmit TMBIM6 to Promote the Malignant Behavior of Hepatocellular Carcinoma via Activating PI3K/AKT Pathway
title_short RETRACTED: Exosomes From Cancer-Associated Mesenchymal Stem Cells Transmit TMBIM6 to Promote the Malignant Behavior of Hepatocellular Carcinoma via Activating PI3K/AKT Pathway
title_sort retracted exosomes from cancer associated mesenchymal stem cells transmit tmbim6 to promote the malignant behavior of hepatocellular carcinoma via activating pi3k akt pathway
topic hepatocellular carcinoma
cancer-associated mesenchymal stem cells
exosomes
TMBIM6
cancer progression
url https://www.frontiersin.org/articles/10.3389/fonc.2022.868726/full
work_keys_str_mv AT chuzhishang retractedexosomesfromcancerassociatedmesenchymalstemcellstransmittmbim6topromotethemalignantbehaviorofhepatocellularcarcinomaviaactivatingpi3kaktpathway
AT mike retractedexosomesfromcancerassociatedmesenchymalstemcellstransmittmbim6topromotethemalignantbehaviorofhepatocellularcarcinomaviaactivatingpi3kaktpathway
AT linliu retractedexosomesfromcancerassociatedmesenchymalstemcellstransmittmbim6topromotethemalignantbehaviorofhepatocellularcarcinomaviaactivatingpi3kaktpathway
AT congwang retractedexosomesfromcancerassociatedmesenchymalstemcellstransmittmbim6topromotethemalignantbehaviorofhepatocellularcarcinomaviaactivatingpi3kaktpathway
AT yufangliu retractedexosomesfromcancerassociatedmesenchymalstemcellstransmittmbim6topromotethemalignantbehaviorofhepatocellularcarcinomaviaactivatingpi3kaktpathway
AT xinzheng retractedexosomesfromcancerassociatedmesenchymalstemcellstransmittmbim6topromotethemalignantbehaviorofhepatocellularcarcinomaviaactivatingpi3kaktpathway